Recurrent and founder mutations in the Netherlands Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation

被引:10
作者
Aalberts, J. J. J. [2 ]
Schuurman, A. G. [1 ]
Pals, G. [3 ]
Hamel, B. J. C. [4 ]
Bosman, G. [1 ]
Hilhorst-Hofstee, Y. [5 ]
Barge-Schaapveld, D. Q. C. M. [6 ]
Mulder, B. J. M. [7 ]
van den Berg, M. P. [2 ]
van Tintelen, J. P. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Ctr Thorax, NL-9700 RB Groningen, Netherlands
[3] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands
[5] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[6] Univ Amsterdam, Dept Clin Genet, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[7] Univ Amsterdam, Dept Cardiol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
关键词
Marfan Syndrome/genetics; Microfilament Proteins; Mutation; Missense; Netherlands; TGF-BETA ACTIVATION; 1009; PROBANDS; MOUSE MODEL; GENE; FIBRILLINOPATHIES; PATHOGENESIS; DISORDERS;
D O I
10.1007/BF03091743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Methods. Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene. Typical characteristics of MPS that have been described include dolichostenomelia, ectopia lentis and aortic root dilatation. However, there is great clinical variability in the expression of the syndrome's manifestations, both between and within families. Here we discuss the clinical variability of MFS by describing a large four-generation Dutch family with MFS. Results. Nineteen individuals of one family with a single missense FBN1 mutation (c.7916A>G) were identified. The same mutation was found in one unrelated person. Clinical variability was extensive and not all mutation carriers fulfilled the diagnostic criteria for MFS. Some patients only expressed mild skeletal abnormalities, whereas aortic root dilation was present in eight patients, an acute type A aortic dissection was recorded in two other patients, and a mitral valve prolapse was present in eight patients. In some patients cardiac features were not present on initial screening, but did however develop over time. Conclusion. MFS is a clinically highly variable syndrome, which means a meticulous evaluation of suspected cases is crucial. Mutation carriers should be re-evaluated regularly as cardiovascular symptoms may develop over time. (Neth Heart J 2010;18:85-9.)
引用
收藏
页码:85 / 89
页数:5
相关论文
共 22 条
[1]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[2]   Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphlism database [J].
Collod-Béroud, G ;
Le Bourdelles, S ;
Ades, L ;
Ala-Kokko, L ;
Booms, P ;
Boxer, M ;
Child, A ;
Comeglio, P ;
De Paepe, A ;
Hyland, JC ;
Holman, K ;
Kaitila, I ;
Loeys, B ;
Matyas, G ;
Nuytinck, L ;
Peltonen, L ;
Rantamaki, T ;
Robinson, P ;
Steinmann, B ;
Junien, C ;
Béroud, C ;
Boileau, C .
HUMAN MUTATION, 2003, 22 (03) :199-208
[3]   Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome [J].
De Backer, J. ;
Loeys, B. ;
Leroy, B. ;
Coucke, P. ;
Dietz, H. ;
De Paepe, A. .
CLINICAL GENETICS, 2007, 72 (03) :188-198
[4]  
DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO
[5]  
2-R
[6]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339
[7]   Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies:: an international study of 1009 probands [J].
Faivre, L. ;
Collod-Beroud, G. ;
Child, A. ;
Callewaert, B. ;
Loeys, B. L. ;
Binquet, C. ;
Gautier, E. ;
Arbustini, E. ;
Mayer, K. ;
Arslan-Kirchner, M. ;
Stheneur, C. ;
Kiotsekoglou, A. ;
Comeglio, P. ;
Marziliano, N. ;
Halliday, D. ;
Beroud, C. ;
Bonithon-Kopp, C. ;
Claustres, M. ;
Plauchu, H. ;
Robinson, P. N. ;
Ades, L. ;
De Backer, J. ;
Coucke, P. ;
Francke, U. ;
De Paepe, A. ;
Boileau, C. ;
Jondeau, G. .
JOURNAL OF MEDICAL GENETICS, 2008, 45 (06) :384-390
[8]   Clinical and Molecular Study of 320 Children With Marfan Syndrome and Related Type I Fibrillinopathies in a Series of 1009 Probands With Pathogenic FBN1 Mutations [J].
Faivre, Laurence ;
Masurel-Paulet, Alice ;
Collod-Beroud, Gwenaelle ;
Callewaert, Bert L. ;
Child, Anne H. ;
Stheneur, Chantal ;
Binquet, Christine ;
Gautier, Elodie ;
Chevallier, Bertrand ;
Huet, Frederic ;
Loeys, Bart L. ;
Arbustini, Eloisa ;
Mayer, Karin ;
Arslan-Kirchner, Mine ;
Kiotsekoglou, Anatoli ;
Comeglio, Paolo ;
Grasso, Maurizia ;
Halliday, Dorothy J. ;
Beroud, Christophe ;
Bonithon-Kopp, Claire ;
Claustres, Mireille ;
Robinson, Peter N. ;
Ades, Lesley ;
De Backer, Julie ;
Coucke, Paul ;
Francke, Uta ;
De Paepe, Anne ;
Boileau, Catherine ;
Jondeau, Guillaume .
PEDIATRICS, 2009, 123 (01) :391-398
[9]   Phenotypic variability of cardiovascular manifestations in Marfan Syndrome - Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism [J].
Giusti, B ;
Porciani, MC ;
Brunelli, T ;
Evangelisti, L ;
Fedi, S ;
Gensini, GF ;
Abbate, R ;
Sani, G ;
Yacoub, M ;
Pepe, G .
EUROPEAN HEART JOURNAL, 2003, 24 (22) :2038-2045
[10]  
Gray JR, 1998, CLIN GENET, V54, P124